ONCOTHERAPY SCIENCE, INC.

Press Releases OncoTherapy Science, Inc.

Equities

4564

JP3202150003

Delayed Japan Exchange Other stock markets 02:00:00 2024-05-14 am EDT			5-day change	1st Jan Change
16 ^JPY	0.00%		-5.88%	-30.43%

Apr. 29	Poland's Tusk calls prosecutor over potential Orlen scandal	RE
Apr. 22	OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Triple Negative Breast Cancer Pipeline, FDA Approvals, Unmet Needs, Preclinical and Discovery Stage Product, and Companies 2024 (Updated)	May. 14	AQ
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 \| Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.	Dec. 05	AQ
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer	22-09-12	PU
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine	20-10-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW